- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1559-131X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
CDK9 inhibitors in multiple myeloma: a review of progress and perspectives ; volume:39 ; number:4 ; day:29 ; month:1 ; year:2022 ; pages:1-15 ; date:4.2022
Medical oncology ; 39, Heft 4 (29.1.2022), 1-15, 4.2022
- Urheber
-
Borowczak, Jędrzej
Szczerbowski, Krzysztof
Ahmadi, Navid
Szylberg, Łukasz
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12032-021-01636-1
- URN
-
urn:nbn:de:101:1-2022052518503370953766
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 05:25 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Borowczak, Jędrzej
- Szczerbowski, Krzysztof
- Ahmadi, Navid
- Szylberg, Łukasz
- SpringerLink (Online service)
Ähnliche Objekte (12)
Research Progress on Ferroptosis in Multiple Myeloma
Immune checkpoint inhibitors for multiple myeloma immunotherapy
CIK Cells and HDAC Inhibitors in Multiple Myeloma
Multiple myeloma
Geranylgeranyl diphosphate synthase inhibitor and proteasome inhibitor combination therapy in multiple myeloma
From transplant to novel cellular therapies in multiple myeloma : : european myeloma network guidelines and future perspectives
Editorial: Molecular imaging in multiple myeloma: an update and future perspectives
Updated Perspectives on the Management of Relapsed and Refractory Multiple Myeloma
Updated Perspectives on the Management of Relapsed and Refractory Multiple Myeloma
Cardiac events during treatment with proteasome inhibitor therapy for multiple myeloma
Tetrahydrobiopterin induces proteasome inhibitor resistance and tumor progression in multiple myeloma
MAFb protein confers intrinsic resistance to proteasome inhibitors in multiple myeloma
Research Progress on Ferroptosis in Multiple Myeloma
Immune checkpoint inhibitors for multiple myeloma immunotherapy
CIK Cells and HDAC Inhibitors in Multiple Myeloma
Multiple myeloma
Geranylgeranyl diphosphate synthase inhibitor and proteasome inhibitor combination therapy in multiple myeloma
From transplant to novel cellular therapies in multiple myeloma : : european myeloma network guidelines and future perspectives
Editorial: Molecular imaging in multiple myeloma: an update and future perspectives
Updated Perspectives on the Management of Relapsed and Refractory Multiple Myeloma
Updated Perspectives on the Management of Relapsed and Refractory Multiple Myeloma
Cardiac events during treatment with proteasome inhibitor therapy for multiple myeloma
Tetrahydrobiopterin induces proteasome inhibitor resistance and tumor progression in multiple myeloma
MAFb protein confers intrinsic resistance to proteasome inhibitors in multiple myeloma
Research Progress on Ferroptosis in Multiple Myeloma
Immune checkpoint inhibitors for multiple myeloma immunotherapy
CIK Cells and HDAC Inhibitors in Multiple Myeloma
Multiple myeloma
Geranylgeranyl diphosphate synthase inhibitor and proteasome inhibitor combination therapy in multiple myeloma
From transplant to novel cellular therapies in multiple myeloma : : european myeloma network guidelines and future perspectives
Editorial: Molecular imaging in multiple myeloma: an update and future perspectives
Updated Perspectives on the Management of Relapsed and Refractory Multiple Myeloma
Updated Perspectives on the Management of Relapsed and Refractory Multiple Myeloma
Cardiac events during treatment with proteasome inhibitor therapy for multiple myeloma
Tetrahydrobiopterin induces proteasome inhibitor resistance and tumor progression in multiple myeloma